Volume 202, Issue 3 , Pages 239.e1-239.e10, March 2010
An international trial of antioxidants in the prevention of preeclampsia (INTAPP)
Objective
We sought to investigate whether prenatal vitamin C and E supplementation reduces the incidence of gestational hypertension (GH) and its adverse conditions among high- and low-risk women.
Study Design
In a multicenter randomized controlled trial, women were stratified by the risk status and assigned to daily treatment (1 g vitamin C and 400 IU vitamin E) or placebo. The primary outcome was GH and its adverse conditions.
Results
Of the 2647 women randomized, 2363 were included in the analysis. There was no difference in the risk of GH and its adverse conditions between groups (relative risk, 0.99; 95% confidence interval, 0.78–1.26). However, vitamins C and E increased the risk of fetal loss or perinatal death (nonprespecified) as well as preterm prelabor rupture of membranes.
Conclusion
Vitamin C and E supplementation did not reduce the rate of preeclampsia or GH, but increased the risk of fetal loss or perinatal death and preterm prelabor rupture of membranes.
Key words: preeclampsia, randomized controlled trial, vitamins C and E
To access this article, please choose from the options below
Sponsored by the Canadian Institutes of Health Research.
The racing flag logo above indicates that this article was rushed to press for the benefit of the scientific community.
Cite this article as: Xu H, Perez-Cuevas R, Xiong X, et al. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010;202:239.e1-10.
PII: S0002-9378(10)00080-3
doi:10.1016/j.ajog.2010.01.050
© 2010 Mosby, Inc. All rights reserved.
Refers to article:
-
Latest research from the 2010 meeting of the Society for Maternal-Fetal Medicine
Volume 202, Issue 3 , Pages 239.e1-239.e10, March 2010
